RMH Holdings Limited (HKG:8437)
0.1550
-0.0010 (-0.65%)
Sep 24, 2025, 3:10 PM HKT
RMH Holdings Revenue
RMH Holdings had revenue of 2.09M SGD in the half year ending June 30, 2025, with 56.74% growth. This brings the company's revenue in the last twelve months to 2.22M, down -67.55% year-over-year. In the year 2024, RMH Holdings had annual revenue of 5.13M with 61.26% growth.
Revenue (ttm)
2.22M SGD
Revenue Growth
-67.55%
P/S Ratio
0.75
Revenue / Employee
49.36K SGD
Employees
45
Market Cap
10.32M HKD
Revenue Chart
* This company reports financials in SGD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.13M | 1.95M | 61.26% |
Dec 31, 2023 | 3.18M | -1.06M | -25.02% |
Dec 31, 2022 | 4.24M | 4.00M | 1,681.93% |
Dec 31, 2021 | 238.00K | -8.00M | -97.11% |
Dec 31, 2020 | 8.24M | 1.01M | 13.99% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
JD Health International | 71.34B |
Hansoh Pharmaceutical Group Company | 14.45B |
WuXi Biologics | 21.98B |
Innovent Biologics | 12.52B |
Sino Biopharmaceutical | 33.49B |
Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |
Akeso | 2.75B |